Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07339995

Fertility Outcomes of Ovarian Tissue Cryopreservation

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
Female
Age
0 Years – 18 Years
Healthy volunteers
Not accepted

Summary

With the advancement of assisted reproductive technology, more young cancer patients can consider having children. Ovaries and testes are important reproductive organs, and drugs, diseases, chemotherapy, and radiotherapy can all damage them. Reproductive preservation technology aims to protect patients whose reproductive ability has been damaged due to gonadotoxic drug therapy. Women can preserve their reproductive ability by freezing ovarian tissue cryopreservation so that they can have children in the future. Patients who have undergone or will undergo ovarian tissue cryopreservation in Hong Kong Children's Hospital will be invited to participate in the study. Here, we aim to evaluate the outcomes after ovarian tissue cryopreservation.

Conditions

Interventions

TypeNameDescription
OTHEROvarian tissue freezing and subsequent auto-transplantation after thawingRemoval of the ovarian tissue will be retrieved via laparoscopic surgery under general anesthesia. The ovarian cortical tissue obtained will be transferred on ice to the laboratory for cryopreservation. After medical treatment, if the patient would like to start a family but has experienced premature ovarian failure, she will have ovarian tissue auto-transplantation after thawing.

Timeline

Start date
2026-01-15
Primary completion
2031-01-14
Completion
2032-01-14
First posted
2026-01-14
Last updated
2026-01-14

Source: ClinicalTrials.gov record NCT07339995. Inclusion in this directory is not an endorsement.